Multiple sclerosis (MS) is a highly prevalent disease in young people caused by the degeneration of the myelin sheath of neurons in the central nervous system (CNS) (
1,
2). The prevalence of MS is 100 per 100,000 people in Iran, and women are two to three times more likely than men to be afflicted by MS (
3). This chronic and progressive disease runs an unpredictable yet homogeneous course, following an advanced secondary stage and a common mild period (
4). Multiple sclerosis leads to a wide range of neurological symptoms, e.g., blurred vision, loss of balance, muscle weakness, and sensory disturbances (
5). Recent research has implicated environmental, genetic, immunological, and microbiological factors in its etiology (
6,
7). Multiple sclerosis is classified as an autoimmune disease in which the immune system attacks the brain and spinal cord, thereby disrupting their functioning. Since the CNS links all bodily functions and activities, MS can cause various side effects (
8,
9).
Problems with balance and controlling the body’s position are the most common challenges experienced by patients with MS with a high rate of falls (
10). Numerous studies have confirmed that MS patients’ falling is associated with their dynamic balance disorder. Based on the literature, people who had experienced falling demonstrated poorer performance on balance and up-and-go tests, which assess imbalance in walking and transitions (
11,
12). Fear of falling (FOF) is described as a constant concern about falling that may eventually limit daily activities, diminish self-confidence in balance, and ultimately lead to muscle weakness, immobility, and reduced quality of life (
13). It can also cause psychological impacts, such as fatigue, lack of social participation, and isolation. Fear of falling can thus cause psychological as well as physical injuries in patients (
14). Patients with MS suffer from musculoskeletal, neurological, and balance disorders. The Tinetti test, clinical tests (e.g., standing on one foot, standing with eyes closed, standing with legs open and closed), and walking time test have shown that patients with MS have serious trouble with balance. Balance depends on visual, proprioceptive, and vestibular senses, as well as appropriate motor responses, which are impaired in patients with MS and diminish their balance (
15,
16).
Multiple sclerosis as a chronic disease causes depression, anxiety, worry, hopelessness, and disability in performing occupational tasks and social functioning while also negatively impacting familial relationships (
17). Disability is a serious symptom and consequence of MS. Disability means the existence of a functional problem at the physical, personal, and social level in one or several areas of life in interaction with environmental factors and health conditions (
18,
19). The clinical features of the disease and the emotional and psychological problems of patients with MS lead to disability in different spheres of life, including diminished ability to adapt to the disease, occupational dysfunction, decreased ability to move and walk, fatigue, and aggravated life problems (
20). Disability leads to emotional distress and is a major dimension of MS patients’ reduced quality of life. People with MS experience different degrees of disability, and this disease is a common cause of disability in young people (
21,
22). Common motor symptoms associated with disability in patients with MS include diminished balance, strength, endurance, and walking speed (
23). Scholz et al. (
10) showed that patients with MS who had a greater FOF were more likely to fall, walked more slowly, took shorter strides, had a larger ellipse sway area, and suffered from a severer disability.
Imbalance in MS and loss of coordination of organs begin with muscle weakness and spasms. Falling is one of the biggest problems that result from an imbalance in MS. Some patients with MS are out of balance when walking, and their gait is uncoordinated. Examining the factors affecting functioning and determining their importance can lay the ground for many strategic decisions. As such, it is essential to know which variables and to what extent they affect MS patients' FOF. As a practical objective, the results of this study can help patients with MS control their disease, decelerate its progressive course, enjoy a hopeful life, and experience fewer physical and psychological symptoms. Also, understanding and explaining the relationship between FOF and disability in patients with MS can be a basis for designing and implementing intervention programs to treat these patients.